View of Transarterial Chemoembolization (TACE) Combined with Quadruple Therapy (XELOX Regimen + Tislelizumab + Surufatinib) for the Treatment of Advanced Primary Hepatic Neuroendocrine Carcinoma: A Case Report

Return to Article Details Transarterial Chemoembolization (TACE) Combined with Quadruple Therapy (XELOX Regimen + Tislelizumab + Surufatinib) for the Treatment of Advanced Primary Hepatic Neuroendocrine Carcinoma: A Case Report Download Download PDF

Cited by

	All	Since 2021
Citations	2130	1647
h-index	21	17
i10-index	34	25

0

680

340

170

510

2009201020112012201320142015201620172018201920202021202220232024202520267 4 13 24 14 19 24 20 34 50 88 141 665 261 205 224 208 74